About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

12-month Study of AMG 073 in Renal Osteodystrophy

NCT00527085·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Amgen

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

18 years of age of greater
Using effective contraceptive measures
iPTH greater than or equal to 300 pg/mL
Serum Calcium greater than or equal to 8.4 mg/dL; Hemoglobin greater than 9
Stable hemodialysis for 1 month prior to day 1

You may not be if

Any unstable medical condition
Pregnant or nursing women Recent parathyroidectomy
Change in Vitamin D therapy
Recent MI, Seizure, Malignancy, GI Disorder
Inability to swallow tablets

The record

StatusCompleted

PhasePhase 2

Taking part45

StartedOct 2001

UpdatedMay 8, 2013

Conditions

Renal Osteodystrophy

Clareo Health | 12-month Study of AMG 073 in Renal Osteodystrophy